Interferon beta-1b biosimilar (InSight Biopharmaceuticals)
干扰素β-1b生物类似药 (InSight Biopharmaceuticals)
Report date: 2022/02/21 13:59:37
Base Information
Drug NameInterferon beta-1b biosimilar (InSight Biopharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2015/01/01
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesInsight Biopharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesInsight Biopharmaceuticals
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A